OG Anunoby: Everything you need to know

OG Anunoby

#8 PF

New York Knicks

Status

GTD - Hamstring - Strain Expected Return: 2026-05-19

STATS

Career Averages

PTS

REB

AST

BLK

STL

13.3

4.5

1.7

0.6

1.3

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	67	67	33.2	16.7	5.2	2.2	0.7	1.6	1.8	5	2.3	6.1	38.6%	3.5	5.9	58.4%	5.8	12.0	48.4%	2.7	3.3	82.8%	1.3	4.0	2.4	1.2	+407	62.0%
2024-25	74	74	36.6	18.0	4.8	2.2	0.9	1.5	1.4	1	2.3	6.2	37.2%	4.3	7.7	56.1%	6.6	13.9	47.6%	2.5	3.1	81.0%	1.3	3.5	2.3	1.6	+301	59.1%
2023-24	50	50	34.0	14.7	4.2	2.1	0.7	1.4	1.6	0	2.0	5.3	38.2%	3.6	6.2	58.1%	5.6	11.5	48.9%	1.3	1.8	75.3%	0.9	3.2	2.4	1.3	+390	59.5%
2022-23	67	67	35.6	16.8	5.0	2.0	0.7	1.9	2.0	2	2.1	5.5	38.7%	4.2	7.7	53.9%	6.3	13.2	47.6%	2.1	2.5	83.8%	1.4	3.5	3.0	1.0	+132	58.6%
2021-22	48	48	36.0	17.1	5.5	2.6	0.5	1.5	1.7	3	2.4	6.6	36.3%	4.0	7.9	51.1%	6.4	14.5	44.3%	1.9	2.5	75.4%	1.5	4.0	2.7	1.6	+138	54.9%
2020-21	43	43	33.3	15.9	5.5	2.2	0.7	1.5	1.7	3	2.4	6.1	39.8%	3.4	6.0	56.2%	5.8	12.1	48.0%	1.9	2.4	78.4%	1.3	4.3	2.7	1.3	+119	60.5%
2019-20	69	68	29.9	10.6	5.3	1.6	0.7	1.4	1.1	5	1.3	3.3	39.0%	2.9	4.9	58.3%	4.1	8.2	50.5%	1.0	1.5	70.6%	1.2	4.1	2.4	1.4	+273	60.0%
2018-19	67	6	20.2	7.0	2.9	0.7	0.3	0.7	0.8	0	1.0	3.0	33.2%	1.7	3.0	57.4%	2.7	6.0	45.3%	0.5	0.9	58.1%	0.9	2.1	2.1	0.9	-49	54.4%
2017-18	74	62	20.0	5.9	2.5	0.7	0.2	0.7	0.6	0	1.0	2.7	37.1%	1.2	2.0	60.4%	2.2	4.7	47.1%	0.5	0.8	62.9%	0.6	1.9	1.8	1.2	+291	58.7%
Career	559	485	30.6	13.3	4.5	1.7	0.6	1.3	1.4	19	1.8	4.8	37.7%	3.1	5.6	56.1%	5.0	10.4	47.6%	1.6	2.1	77.4%	1.1	3.3	2.4	1.3	+2002	58.8%

Career Averages

PTS

REB

AST

BLK

STL

14.5

5.1

1.3

0.9

1.3

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	8	8	35.3	21.4	7.5	1.3	1.1	1.9	0.5	2	2.6	4.9	53.8%	4.9	7.3	67.2%	7.5	12.1	61.9%	3.8	4.6	81.1%	1.1	6.4	2.5	2.5	+118	75.5%
2024-25	18	18	39.2	16.3	4.6	1.3	1.2	2.0	1.7	0	2.3	6.7	33.9%	3.4	7.0	49.2%	5.7	13.7	41.7%	2.6	3.2	81.0%	1.3	3.3	2.7	0.8	-36	53.9%
2023-24	9	9	36.0	15.1	6.0	1.1	1.0	0.9	1.1	1	1.8	4.3	41.0%	4.4	8.0	55.6%	6.2	12.3	50.5%	0.9	1.4	61.5%	0.8	5.2	1.7	1.0	+3	58.3%
2021-22	6	6	36.0	17.3	4.0	2.5	0.2	1.0	1.7	0	2.3	6.8	34.1%	4.2	6.8	61.0%	6.5	13.7	47.6%	2.0	2.7	75.0%	1.2	2.8	3.0	1.5	-31	58.4%
2019-20	11	11	35.7	10.5	6.9	1.2	1.2	1.0	1.5	2	1.5	3.7	41.5%	2.1	4.3	48.9%	3.6	8.0	45.5%	1.6	2.5	64.3%	2.4	4.5	2.5	0.8	+22	57.3%
2017-18	10	10	23.8	7.9	2.1	0.7	0.4	0.6	0.6	0	1.3	2.9	44.8%	1.6	2.3	69.6%	2.9	5.2	55.8%	0.8	1.1	72.7%	0.9	1.2	2.3	1.2	-23	69.5%
Career	62	62	34.8	14.5	5.1	1.3	0.9	1.3	1.2	5	2.0	5.0	39.4%	3.3	5.9	55.9%	5.3	10.9	48.3%	2.0	2.6	75.5%	1.3	3.8	2.5	1.0	+53	60.0%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/9	MIN	W 100-95	23	8	6	2	0	1	1	6	2	33.3%	2	1	50.0%	8	3	37.5%	0	0	0.0%	2	4	2.0	+3	1	10	50.0%
10/4	PHI	W 113-104	16	13	2	1	0	1	1	5	3	60.0%	2	1	50.0%	7	4	57.1%	2	2	100.0%	0	2	1.0	+20	1	13	82.5%
Preseason Totals			20.4	10.5	4.0	1.5	0.0	1.0	1.0	5.5	2.5	45.5%	2.0	1.0	50.0%	7.5	3.5	46.7%	1.0	1.0	100.0%	1.0	3.0	1.5	+23	1.0	12.5	66.1%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/9	BOS	W 112-106	36	13	4	1	0	2	1	7	3	42.9%	3	1	33.3%	10	4	40.0%	2	2	100.0%	0	4	1.0	+3	3	10	59.7%
4/6	ATL	W 108-105	36	22	5	1	2	0	3	10	4	40.0%	4	3	75.0%	14	7	50.0%	4	4	100.0%	2	3	0.3	+10	1	22	69.8%
4/3	CHI	W 136-96	30	31	8	2	1	0	1	10	7	70.0%	5	2	40.0%	15	9	60.0%	6	6	100.0%	0	8	2.0	+32	2	37	87.9%
4/1	MEM	W 130-119	39	25	13	3	2	1	1	8	4	50.0%	9	4	44.4%	17	8	47.1%	6	5	83.3%	3	10	3.0	+15	3	31	63.6%
3/31	HOU	L 111-94	38	8	6	0	1	2	0	8	2	25.0%	1	1	100.0%	9	3	33.3%	0	0	0.0%	1	5	0.0	-14	1	10	44.4%
3/29	OKC	L 111-100	32	10	0	3	0	1	1	7	2	28.6%	2	0	0.0%	9	2	22.2%	4	4	100.0%	0	0	3.0	-17	4	4	46.5%
3/26	CHA	L 114-103	39	17	3	2	1	0	2	9	5	55.6%	1	1	100.0%	10	6	60.0%	0	0	0.0%	1	2	1.0	-1	2	18	85.0%
3/24	NOP	W 121-116	39	21	4	4	1	3	0	13	5	38.5%	3	2	66.7%	16	7	43.8%	2	2	100.0%	0	4	0.0	+17	4	20	62.2%
3/22	WAS	W 145-113	29	9	2	0	0	0	4	3	1	33.3%	4	2	50.0%	7	3	42.9%	2	2	100.0%	0	2	0.0	+13	0	4	57.1%
3/20	BKN	W 93-92	35	16	3	1	1	2	4	6	1	16.7%	7	6	85.7%	13	7	53.8%	2	1	50.0%	0	3	0.3	+14	2	9	57.6%
3/17	IND	W 136-110	29	26	8	4	0	1	1	5	4	80.0%	8	6	75.0%	13	10	76.9%	2	2	100.0%	1	7	4.0	+25	2	33	93.7%
3/15	GSW	W 110-107	29	14	4	1	0	0	1	4	2	50.0%	2	1	50.0%	6	3	50.0%	6	6	100.0%	3	1	1.0	+0	3	15	81.0%
3/13	IND	W 101-92	34	25	8	5	0	0	2	4	2	50.0%	12	6	50.0%	16	8	50.0%	9	7	77.8%	1	7	2.5	+13	2	29	62.6%
3/11	UTA	W 134-117	30	22	2	1	1	2	1	5	3	60.0%	5	4	80.0%	10	7	70.0%	5	5	100.0%	1	1	1.0	+11	3	24	90.2%
3/9	LAC	L 126-118	37	22	6	2	0	2	4	8	3	37.5%	7	5	71.4%	15	8	53.3%	4	3	75.0%	2	4	0.5	-3	2	22	65.6%
3/8	LAL	L 110-97	37	13	8	1	0	1	2	4	1	25.0%	7	4	57.1%	11	5	45.5%	2	2	100.0%	3	5	0.5	-9	4	10	54.7%
3/6	DEN	W 142-103	31	34	7	5	1	4	0	11	6	54.5%	6	5	83.3%	17	11	64.7%	6	6	100.0%	3	4	0.0	+17	1	47	86.6%
3/4	OKC	L 103-100	37	16	3	0	2	3	3	13	4	30.8%	4	2	50.0%	17	6	35.3%	0	0	0.0%	0	3	0.0	-4	3	7	47.1%
3/3	TOR	W 111-95	26	15	5	0	0	0	2	2	2	100.0%	4	3	75.0%	6	5	83.3%	4	3	75.0%	0	5	0.0	+8	4	14	96.6%
3/1	SAS	W 114-89	34	12	5	1	1	1	1	5	2	40.0%	6	3	50.0%	11	5	45.5%	0	0	0.0%	2	3	1.0	+16	1	12	54.5%
2/27	MIL	W 127-98	28	24	3	3	0	2	1	7	5	71.4%	3	3	100.0%	10	8	80.0%	4	3	75.0%	0	3	3.0	+20	3	27	102.0%
2/24	CLE	L 109-94	34	5	3	2	1	0	1	6	1	16.7%	3	1	33.3%	9	2	22.2%	0	0	0.0%	0	3	2.0	-12	2	0	27.8%
2/22	CHI	W 105-99	33	9	9	2	1	2	1	4	0	0.0%	7	4	57.1%	11	4	36.4%	2	1	50.0%	2	7	2.0	+17	2	13	37.9%
2/21	HOU	W 108-106	40	20	2	1	0	4	1	7	2	28.6%	9	6	66.7%	16	8	50.0%	2	2	100.0%	1	1	1.0	+6	2	16	59.2%
2/19	DET	L 126-111	31	8	0	0	4	0	0	8	1	12.5%	5	2	40.0%	13	3	23.1%	2	1	50.0%	0	0	0.0	+1	4	4	28.8%
2/4	DEN	W 134-127	47	20	8	4	0	0	0	9	4	44.4%	8	3	37.5%	17	7	41.2%	2	2	100.0%	3	5	0.0	+13	3	21	55.9%
2/3	WAS	W 132-101	27	19	4	2	1	1	1	6	3	50.0%	5	3	60.0%	11	6	54.5%	5	4	80.0%	0	4	2.0	+13	2	20	72.0%
2/1	LAL	W 112-100	33	25	8	3	0	3	1	8	4	50.0%	7	5	71.4%	15	9	60.0%	4	3	75.0%	3	5	3.0	+21	1	32	74.6%
1/30	POR	W 127-97	30	24	6	3	1	0	3	8	4	50.0%	8	6	75.0%	16	10	62.5%	0	0	0.0%	1	5	1.0	+34	3	21	75.0%
1/28	TOR	W 119-92	33	26	3	5	2	6	0	6	2	33.3%	12	9	75.0%	18	11	61.1%	3	2	66.7%	0	3	0.0	+18	3	32	67.3%
1/27	SAC	W 103-87	32	15	2	0	0	2	7	4	3	75.0%	3	2	66.7%	7	5	71.4%	2	2	100.0%	1	1	0.0	+5	3	8	95.2%
1/24	PHI	W 112-109	36	23	7	4	0	2	2	3	2	66.7%	12	8	66.7%	15	10	66.7%	2	1	50.0%	3	4	2.0	-8	0	30	72.4%
1/21	BKN	W 120-66	29	5	5	3	0	0	3	0	0	0.0%	4	2	50.0%	4	2	50.0%	2	1	50.0%	1	4	1.0	+28	2	5	51.2%
1/19	DAL	L 114-97	31	9	6	2	1	3	3	4	1	25.0%	4	2	50.0%	8	3	37.5%	2	2	100.0%	2	4	0.7	-12	3	11	50.7%
1/17	PHX	L 106-99	38	21	8	5	0	3	4	7	1	14.3%	10	5	50.0%	17	6	35.3%	10	8	80.0%	3	5	1.3	-4	1	25	49.1%
1/15	GSW	L 126-113	37	25	4	1	0	1	1	4	1	25.0%	16	9	56.3%	20	10	50.0%	5	4	80.0%	1	3	1.0	-6	2	20	56.3%
1/14	SAC	L 112-101	27	15	3	4	2	0	1	6	0	0.0%	7	5	71.4%	13	5	38.5%	8	5	62.5%	1	2	4.0	-16	4	11	45.4%
1/11	POR	W 123-114	34	24	7	3	0	1	1	7	4	57.1%	8	5	62.5%	15	9	60.0%	2	2	100.0%	1	6	3.0	+10	3	24	75.6%
1/9	PHX	L 112-107	37	15	8	3	0	0	1	5	2	40.0%	4	1	25.0%	9	3	33.3%	9	7	77.8%	3	5	3.0	+5	1	18	57.9%
1/7	LAC	W 123-111	31	20	3	0	0	1	2	3	2	66.7%	7	6	85.7%	10	8	80.0%	2	2	100.0%	0	3	0.0	+7	3	21	91.9%
1/5	DET	L 121-90	28	5	2	1	1	3	2	2	0	0.0%	2	1	50.0%	4	1	25.0%	4	3	75.0%	0	2	0.5	-31	2	6	43.4%
1/3	PHI	L 130-119	37	19	6	6	1	1	4	5	3	60.0%	6	3	50.0%	11	6	54.5%	4	4	100.0%	4	2	1.5	-8	3	21	74.5%
1/2	ATL	L 111-99	34	19	10	1	0	2	3	6	1	16.7%	7	4	57.1%	13	5	38.5%	10	8	80.0%	2	8	0.3	-14	4	20	54.6%
12/31	SAS	L 134-132	34	9	5	2	1	2	2	5	0	0.0%	5	3	60.0%	10	3	30.0%	4	3	75.0%	0	5	1.0	-25	4	7	38.3%
12/29	NOP	W 130-125	37	23	11	1	1	3	2	8	1	12.5%	14	7	50.0%	22	8	36.4%	6	6	100.0%	2	9	0.5	+16	3	21	46.7%
12/27	ATL	W 128-125	38	15	10	5	1	3	1	5	2	40.0%	5	1	20.0%	10	3	30.0%	7	7	100.0%	3	7	5.0	+0	4	27	57.3%
12/25	CLE	W 126-124	33	8	2	2	1	0	1	4	1	25.0%	3	2	66.7%	7	3	42.9%	1	1	100.0%	0	2	2.0	-3	1	9	53.8%
12/21	MIA	W 132-125	33	18	2	3	2	1	4	6	2	33.3%	6	4	66.7%	12	6	50.0%	5	4	80.0%	0	2	0.8	+3	4	13	63.4%
12/19	PHI	L 116-107	31	2	3	1	1	0	2	4	0	0.0%	5	1	20.0%	9	1	11.1%	0	0	0.0%	2	1	0.5	-11	2	7	11.1%
12/18	IND	W 114-113	33	16	6	1	0	2	3	7	2	28.6%	6	3	50.0%	13	5	38.5%	7	4	57.1%	1	5	0.3	+11	3	12	49.8%
12/13	ORL	W 132-120	40	24	6	4	1	3	4	4	3	75.0%	9	5	55.6%	13	8	61.5%	6	5	83.3%	1	5	1.0	+14	2	28	76.7%
12/9	TOR	W 117-101	35	13	6	1	2	2	3	6	1	16.7%	5	3	60.0%	11	4	36.4%	4	4	100.0%	1	5	0.3	+6	3	13	50.9%
12/7	ORL	W 106-100	27	21	7	0	0	3	0	7	5	71.4%	7	3	42.9%	14	8	57.1%	0	0	0.0%	1	6	0.0	+20	4	20	75.0%
12/5	UTA	W 146-112	22	11	0	1	0	0	2	2	0	0.0%	6	4	66.7%	8	4	50.0%	4	3	75.0%	0	0	0.5	+7	1	7	56.4%
11/14	MIA	W 140-132	5	2	3	0	0	0	0	1	0	0.0%	3	1	33.3%	4	1	25.0%	0	0	0.0%	2	1	0.0	+1	1	0	25.0%
11/12	ORL	L 124-107	33	8	4	1	2	1	3	4	2	50.0%	0	0	0.0%	4	2	50.0%	2	2	100.0%	0	4	0.3	+1	3	9	82.0%
11/11	MEM	W 133-120	35	16	4	3	0	2	4	10	1	10.0%	7	6	85.7%	17	7	41.2%	2	1	50.0%	0	4	0.8	+24	5	9	44.7%
11/9	BKN	W 134-98	27	19	8	3	0	1	1	6	4	66.7%	5	2	40.0%	11	6	54.5%	4	3	75.0%	4	4	3.0	+32	1	26	74.5%
11/5	MIN	W 137-114	31	25	8	1	1	2	1	5	3	60.0%	12	7	58.3%	17	10	58.8%	2	2	100.0%	5	3	1.0	+14	1	30	69.9%
11/3	WAS	W 119-102	32	16	6	2	0	5	2	5	2	40.0%	8	5	62.5%	13	7	53.8%	0	0	0.0%	1	5	1.0	+9	1	20	61.5%
11/2	CHI	W 128-116	34	21	2	4	1	2	1	7	3	42.9%	10	5	50.0%	17	8	47.1%	2	2	100.0%	0	2	4.0	+22	1	20	58.7%
10/31	CHI	L 135-125	36	26	4	3	1	1	1	7	5	71.4%	6	5	83.3%	13	10	76.9%	2	1	50.0%	1	3	3.0	+6	4	27	93.7%
10/28	MIL	L 121-111	33	9	6	5	1	1	2	6	1	16.7%	5	2	40.0%	11	3	27.3%	3	2	66.7%	2	4	2.5	-6	4	7	36.5%
10/26	MIA	L 115-107	36	14	6	1	1	3	2	12	4	33.3%	1	0	0.0%	13	4	30.8%	2	2	100.0%	1	5	0.5	+4	4	11	50.4%
10/24	BOS	W 105-95	29	10	2	1	0	2	1	7	2	28.6%	3	1	33.3%	10	3	30.0%	2	2	100.0%	1	1	1.0	+10	3	4	46.0%
10/22	CLE	W 119-111	37	24	14	2	1	3	4	9	4	44.4%	8	5	62.5%	17	9	52.9%	4	2	50.0%	2	12	0.5	+10	0	32	64.0%
Regular Season Totals			33.5	16.9	5.2	2.2	0.7	1.6	1.9	6.1	2.4	38.9%	6.0	3.5	58.3%	12.1	5.9	48.5%	3.3	2.8	82.8%	1.3	4.0	1.2	+398	2.5	20.3	62.2%

Postseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
5/6	PHI	W 108-102	37	24	5	2	1	4	0	7	2	28.6%	10	7	70.0%	17	9	52.9%	4	4	100.0%	2	3	0.0	+12	3	27	64.0%
5/4	PHI	W 137-98	30	18	3	1	1	0	2	2	2	100.0%	6	5	83.3%	8	7	87.5%	2	2	100.0%	0	3	0.5	+22	3	18	101.4%
4/30	ATL	W 140-89	27	29	7	2	1	4	0	6	4	66.7%	8	7	87.5%	14	11	78.6%	5	3	60.0%	0	7	0.0	+42	0	43	89.5%
4/28	ATL	W 126-97	34	17	10	1	1	2	0	3	2	66.7%	5	3	60.0%	8	5	62.5%	5	5	100.0%	1	9	0.0	+19	2	30	83.3%
4/25	ATL	W 114-98	39	22	10	1	1	1	1	6	3	50.0%	10	6	60.0%	16	9	56.3%	2	1	50.0%	2	8	1.0	+19	3	24	65.2%
4/23	ATL	L 109-108	36	29	9	1	3	1	0	8	4	50.0%	8	5	62.5%	16	9	56.3%	7	7	100.0%	4	5	0.0	-4	3	35	76.0%
4/20	ATL	L 107-106	37	14	8	2	1	2	1	4	2	50.0%	5	2	40.0%	9	4	44.4%	8	4	50.0%	0	8	2.0	-1	3	18	55.9%
4/18	ATL	W 113-102	37	18	8	0	0	1	0	3	2	66.7%	6	4	66.7%	9	6	66.7%	4	4	100.0%	0	8	0.0	+9	3	23	83.6%
Postseason Totals			35.2	21.4	7.5	1.3	1.1	1.9	0.5	4.9	2.6	53.8%	7.3	4.9	67.2%	12.1	7.5	61.9%	4.6	3.8	81.1%	1.1	6.4	2.5	+118	2.5	30.6	75.5%

OG Anunoby: Breaking News

Anunoby (hamstring) has been ruled out for Sunday's Game 4 of the Eastern Conference Semifinals against the 76ers, Jared Schwartz of the New York Post reports. Anunoby will miss a second consecutive contest due to a right hamstring strain, though he can still be considered day-to-day moving forward. With the 28-year-old forward sidelined, Landry Shamet and Miles McBride are candidates for increased playing time.

Anunoby (hamstring) is listed as questionable for Sunday's Game 4 against the 76ers. Anunoby was unable to play in the Sixers' Game 3 win Friday after tweaking his right hamstring in Game 2. He has a chance to return for Game 4, but if he's unable to play, then Miles McBride would likely remain in the Knicks' starting lineup, with Landry Shamet and Jordan Clarkson also seeing extended playing time.

Anunoby (hamstring) is out for Game 3 of the Eastern Conference semifinal-round series versus the 76ers on Friday, Adam Aaronson of PhillyVoice.com reports. Anunoby will hit the sidelines after tweaking his hamstring during Wednesday's Game 2 win, but the good news is that this injury is considered minor and he's being listed as day-to-day. Miles McBride, Jordan Clarkson and Jeremy Sochan will have the chance for some extended minutes while Anunoby is out.